Business Books

Διαχείριση και αξιολόγηση της φαρμακευτικής καινοτομίας στην Ελλάδα, A health economy policy approach

Authors: Giannis Kyriopoulos,Eleytheria Karampli,Elpida Pavi,Konstantinos P. Athanasakis,Katerina Mylona,Nikos Manias,Kostas Athanasakis,Nantia Mpoumpouchairopoulou

The dramatic reduction of human, technological, and financial resources in the healthcare sector calls into question, among other things, the significance and implications of biomedical and...

The dramatic reduction of human, technological, and financial resources in the healthcare sector calls into question, among other things, the significance and implications of biomedical and pharmaceutical innovation in the medical care industry.

The increase in healthcare spending, both nationally and internationally, is not solely due to the rise in volume...

See Description & Specifications See Description & Specifications

Top specs

This product is temporarily unavailable at Skroutz Last updated: about 17 hours ago
Questions

Description & Specifications

The dramatic reduction of human, technological, and financial resources in the healthcare sector calls into question, among other things, the significance and implications of biomedical and pharmaceutical innovation in the medical care industry.

The increase in healthcare spending, both nationally and internationally, is not solely due to the rise in volume and prices, but also concurrently to the phenomena of rapid innovative turnover of pharmaceutical and biomedical products.

Innovation in pharmaceutical care constitutes a complex and multidimensional phenomenon, which, as indicated by relevant scientific documentation, positively contributes to health and the quality of health-related life, but also aids in the development of the research industry and in economic growth through the increase of GDP and employment.

The impact of these parameters must be considered through systematic multicriteria evaluation and inevitably imposes reforms in the pharmaceutical market, as well as in decision-making processes through regulatory interventions.

In this light, it is necessary to reconcile, on one hand, the control of costs due to finite budgets and on the other hand, the increase in expenditure due to the tidal wave of innovation, through appropriate structural changes in healthcare services, to the extent that the assertion holds that "the future of medical care is technological and innovative".

This book attempts to approach the subject from the perspective of international experience and practice with the evident purpose of establishing a well-founded pharmaceutical policy within the framework of national health policy, given that it is of utmost priority to undertake the relevant political and scientific responsibility for the design, management, and control of biomedical and pharmaceutical technology, which constitutes the future of medical care.

Manufacturer

Specifications

Authors
Giannis Kyriopoulos, Eleytheria Karampli, Elpida Pavi, Konstantinos P. Athanasakis, Katerina Mylona, Nikos Manias, Kostas Athanasakis, Nantia Mpoumpouchairopoulou
Publisher
Ekdoseis Kastanioti
Language
Greek
Subtitle
A health economy policy approach
Cover
Soft
Number of Pages
224
Release Date
03/03/2016
Publication Date
2016
Dimensions
14x20.5 cm
ISBN-13
9789600359985

Book Type

Diversity, Equity & Inclusion (DEI)
No

Important information

Specifications are collected from official manufacturer websites. Please verify the specifications before proceeding with your final purchase. If you notice any problem you can report it here.